Chitosan based delivery systems on a length scale: Nano to macro

Soft Materials

Volumn 11, Issue 2, 2013, Pages 125-142

  Pal, Kunal ^a   Behera, Beauty ^a   Roy, Saroj ^b   Sekhar Ray, Sirsendu ^a   Thakur, Goutam ^c  

^a NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^b SVKM s Narsee Monjee Institute of Management Studies   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Chitosan; Hydrogels; Microparticle; Nanoparticle

Indexed keywords

BIOMEDICAL APPLICATIONS; DELIVERY SYSTEMS; DELIVERY VEHICLE; DRUG DELIVERY SYSTEM; IMPLANTABLE DEVICES; LENGTH SCALE; MICRO PARTICLES; NANO PARTICULATES; VERSATILE CHEMISTRY; WOUND HEALING;

BIOCHEMISTRY; DRUG DELIVERY; HYDROGELS; IMPLANTS (SURGICAL); MEDICAL APPLICATIONS; NANOPARTICLES; TISSUE ENGINEERING;

CHITOSAN;

EID: 84872764821     PISSN: 1539445X     EISSN: 15394468     Source Type: Journal    
DOI: 10.1080/1539445X.2011.586082     Document Type: Article

References (224)

1. Basavaraju, K.C., Damappa, T., and Rai, S.K. (2006) Preparation of chitosan and its miscibility studies with gelatin using viscosity, ultrasonic and refractive index. Carbohyd. Polym., 66(3):357-362
2. http://en.wikipedia.org/wiki/Chitosan. 2010
3. Kofuji, K., Isobe, T., and Murata, Y. (2009) Controlled release of alpha-lipoic acid through incorporation into natural polysaccharidebased gel beads. Food Chem., 115(2):483-487
4. Zivanovic, S., et al. (2007) Physical, mechanical, and antibacterial properties of chitosan/PEO blend films. Biomacromolecules, 8(5):1505-1510
5. Martinou, A., Kafetzopoulos, D., andBouriotis, V. (1995) Chitin deacetylation by enzymatic means: Monitoring of deacetylation processes. Carbohyd. Res., 273(2): 235-242
6. Miya, M., et al. (1980) I.R. spectroscopic determination of CONH content in highly deacylated chitosan. Int. J. Biol. Macromol., 2(5):323-324
7. Gupta, K.C., and Jabrail, F.H. (2006) Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman. Carbohyd. Res., 341(6):744-756
8. Lavertu, M., et al. (2003) A validated 1H NMR method for the determination of the degree of deacetylation of chitosan. J. Pharm. Biomed. Anal., 32(6):1149-1158
9. Zhang, Y., et al. (2011) Determination of the degree of deacetylation of chitosan by potentiometric titration preceded by enzymatic pretreatment. Carbohyd. Polym., 83(2):813-817
10. Muzzarelli, R.A.A., and Peter, M. G. (1997) Chitin Handbook; European Chitin Society: Bremin
11. Pal, K., Banthia, A.K., and Majumdar, D.K. (2009) Polymeric Hydrogels: Characterization and Biomedical Applications. Des. Monomers. Polym., 12:197-220
12. Li, L.-H., et al. (2010) Preparation, characterization and antimicrobial activities of chitosan/Ag/ZnO blend films.Chem. Eng. J., 160(1): 378-382
13. Lee, K.W., J.J., Yoon, et al. (2004). Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan. Transplantation Proceedings 36(8):2464-2465
14. Agnihotri, S.A., Mallikarjuna, N.N., and Aminabhavi, T.M. (2004) Recent advances on chitosan-based micro-And nanoparticles in drug delivery. J. Control. Release, 100(1):5-28
15. Felt, O., Buri, P., and Gurny, R. (1998) Chitosan: A unique polysaccharide for drug delivery. Drug Development and Industrial Pharmacy, 24(11):979-993
16. Li, F., Liu, W.G., and Yao, K.D. (2002) Preparation of oxidized glucose-crosslinked N-Alkylated chitosan membrane and in vitro studies of pH-sensitive drug delivery behaviour. Biomaterials, 23(2): 343-347
17. Lorenzo-Lamosa, M., et al., (1998) Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control. Release, 52(1-2):109-118
18. Roy, K., et al. (1999) Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nature Med., 5(4):387
19. Erbacher, P., et al. (1998) Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability. Pharm. Res., 15(9):1332-1339
20. Acosta, E. (2009) Bioavailability of nanoparticles in nutrient and nutraceutical delivery. Curr. Opinion Colloid Interface Sci., 14(1):3-15
21. CHSIR. Chitosan-Fat Blocker. http://www.chsir.com/chitosan.htm. 2010
22. Ormrod, D.J., Holmes, C.C., and Miller, T.E. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis, 138(2):329-334
23. Wuolijoki, E., Hirveol, T., and Ylitaol, P. (1999) Decrease in serum LDL cholesterol with microcrystalline chitosan. Methods Find Exp. Clin. Pharmacol., 21(5):357-361
24. Sciutto, G., and Colombo, P. (1995) Lipid-lowering effect of chitosan dietary integrator and hypocaloric diet in obese subjects. Acta Toxicol. Ther., 16(4):215-230
25. Macchi, G. (1996) A new approach to the treatment of obesity: Chitosan's effect on body weight reduction and plasma cholesterol levels. Acta Toxicol. Ther., 17(4):303-320
26. Zhou, Y., et al. (2011) Photopolymerized water-soluble chitosan-based hydrogel as potential use in tissue engineering. Int. J. Biol.Macromol., 48(3):408-413
27. Sudarshan, N.R., Hoover, D.G., and Knorr, D. (1992) Antibacterial action of chitosan. Food Biotechnol., 6(3):257-272
28. Zivanovic, S., et al. (2004) Molecular weight of chitosan influences antimicrobial activity in oil-in-water emulsions. J. Food Protect., 67:952-959
29. Mohd Nasir, N.F., et al. (2005) Characterization of chitosan-poly (ethylene oxide) blends as haemodialysis membrane. Am. J. Appl. Sci., 2(12):1578-1583
30. Mi, F.-L., Sung, H.-W., and Shyu, S.-S. (2000) Synthesis and characterization of a novel chitosan-based network prepared using naturally occurring crosslinker. J. Polym. Sci. A, 38(15):2804-2814
31. MonteiroJr, O.A.C., and Airoldi, C. (1999) Some studies of crosslinking chitosan-glutaraldehyde interaction in a homogeneous system. Int. J. Biol. Macromol., 26(2-3):119-128
32. Park, S.-B., et al. (2004) Ca-Alginate microspheres encapsulated in chitosan beads. J. Microencapsul., 21(5):485-497
33. Zhao, L., and Mitomo, H. (2009) Hydrogels of dihydroxypropyl chitosan crosslinked with irradiation at paste-like condition. Carbohyd. Polym., 76(2):314-319
34. Jameela, S.R., et al. (2002) Preparation and evaluation of photocrosslinkable chitosan as a drug delivery matrix. J. Appl. Polym. Sci., 86(8):1873-1877
35. Salmawi, K.M.E. (2007) Gamma Radiation-Induced Crosslinked PVA/Chitosan Blends for Wound Dressing. J. Macromol. Sci. A, 44(5):541-545
36. Pulieri, E., et al. (2008) Chitosan/gelatin blends for biomedical applications. J. Biomed. Mat. Res. A, 86A(2):311-322
37. Peppas, N.A., et al. (2000) Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm., 50(1):27-46
38. Hoffman, A.S. (2001). Hydrogels for Biomedical Applications. Annals of the New York Academy of Sciences 944(1):62-73. Chitosan-Based Delivery Systems on a Length Scale 139
39. Campoccia, D., et al. (1998) Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials, 19(23):2101-2127
40. Prestwich, G.D., et al. (1998) Controlled chemical modification of hyaluronic acid: Synthesis, applications, and biodegradation of hydrazide derivatives. J. Control. Release, 53(1-3):93-103
41. Trimukhe, K.D., and Varma, A.J. (2008) Complexation of heavy metals by crosslinked chitin and its deacetylated derivatives. Carbohyd. Polym., 71(1):66-73
42. Kashyap, N., Kumar, N., and Kumar, M.N.V.R. (2005) Hydrogels for Pharmaceutical and Biomedical applications. Crit. Rev. Therapeut. Drug Carrier Syst., 22(2):107-149
43. Peppas, N.A. (1987) Hydrogels in Medicine and Pharmacy. Vol. I-III. CRC Press: Boca Raton, FL.
44. Moura, M.J., Figueiredo, M.M., and Gil, M.H. (2007) Rheological Study of Genipin Cross-Linked Chitosan Hydrogels. Biomacromolecules, 8(12):3823-3829
45. Muzzarelli, R.A.A. (2009) Genipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids. Carbohyd. Polym., 77(1):1-9
46. Bhumkar, D.R., and Pokharkar, V.B. (2006) Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note. AAPS PharmSciTech., 7(2):E1-E6
47. Pandey, R., and Khuller, G.K. (2004) Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers. J. Antimicrob. Chemother., 53(4):635-640
48. Zhu, Y., and Chan-Park, M.B. (2007) Density quantification of collagen grafted on biodegradable polyester: Its application to esophageal smooth muscle cell. Anal. Biochem., 363(1):119-127
49. Pal, K., Paulson, A.T., and Rousseau, D. (2009) Modern Biopolymer Science: Bridging The Divide Between Fundamental Treatise And Industrial Application. 1st ed, Kasapis, S., Norton, I.T., and Ubbink, J.B, eds.; Academic Press: London
50. Nassar, T., et al. (2009) Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug. J. Control. Release, 133(1):77-84
51. Agnihotri, S.M., and Vavia, P.R. (2009) Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomed. Nanotechnol. Biol. Med., 5(1):90-95
52. Carrer, D.C., Vermehren, C., and Bagatolli, L.A. (2008) Pig skin structure and transdermal delivery of liposomes: A two photon microscopy study. J. Control. Release, 132(1):12-20
53. Joshi, M.D., and Müller, R.H. (2009) Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm., 71(2):161-172
54. Allemann, E., Gurny, R., and Doelker, E. (1993) Drug-Loaded Nanoparticles- Preparation, Methods and Drug Targetting Issues. Eur. J. Pharm. Biopharm., 39(5):173-191
55. Kreuter, J. (1996) Nanoparticles and microparticles for drug and vaccine delivery. J. Anat., 189(Pt. 3):503-505
56. in-PharmaTechnologist. Nanotechnology to revolutionise drug delivery. http://www.in-pharmatechnologist.com/Materials-Formulation/ Nanotechnology-to- revolutionise-drug-delivery. 2010
57. Kawashima, Y. (2001) Nanoparticulate systems for improved drug delivery. Adv. Drug Deliv. Rev., 47(1):1-2
58. Wikipedia. Microparticles. http://en.wikipedia.org/wiki/ Microparticles. 2010
59. Brannon-Peppas, L. (1997) Polymers in controlled drug delivery. Med. Plast. Biomater, 4:34-44
60. Ravi Kumar, M.N.V. (2000) Nano and Microparticles as Controlled Drug Delivery Devices. J. Pharm. Pharm. Sci., 3(2):234-258
61. van der Lubben, I.M., et al. (2001) Chitosan microparticles for oral vaccination:: Preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials, 22(7): 687-694
62. LaVan, D.A., McGuire, T., and Langer, R. (2003) Small-scale systems for in vivo drug delivery. Nat. Biotech., 21(10):1184-1191
63. Park, J.H., et al. (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Del. Rev., 62(1):28-41
64. Tiyaboonchai, W. (2003) Chitosan nanoparticles: A promising system for drug delivery. Naresuan Univ. J., 11(3):51-66
65. Janes, K.A., Calvo, P., and Alonso, M.J. (2001) Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Del. Rev., 47(1):83-97
66. Bodmeier, R., Chen, H., and Paeratakul, O. (1989) A novel approach to the delivery of microparticles or nanoparticles. Pharm. Res., 6:413-417
67. Berthold, A., Cremer, K., and Kreuter, J. (1996) Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control. Release, 39:17-25
68. 3O4 composite nanoparticles in tiny pools of water-in-oil microemulsion. Reactive Func. Polym., 66(12):1552-1558
69. Ohya, Y., et al. (1994) Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. J. Macromol. Sci. A, 31(5):629-642
70. de Salamanca, A.E., et al. (2006) Chitosan Nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance. Invest. Ophthalmol. Vis. Sci., 47(4):1416-1425
71. Sharma, V., M. Ali, et al. (2007). Preparation and characterization of chitosan nanoparticles for nose to brain delivery of a cholinesterase inhibitor. Indian Journal of Pharmaceutical Sciences 69(5):712
72. Lee, D.-W., et al. (2006) Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res., 7(1):112-121
73. Zhang, H., et al. (2004) Monodisperse Chitosan Nanoparticles for Mucosal Drug Delivery. Biomacromolecules, 5(6):2461-2468
74. Li, P., et al. (2008) Chitosan-Alginate nanoparticles as a novel drug delivery system for nifedipine. Int. J. Biomed. Sci., 4(3):221-228
75. Chen, J.-Y., et al. (2007) Depositing Cu2O of different morphology on chitosan nanoparticles by an electrochemical method. Carbohyd. Polym., 67(4):623-629
76. Agnihotri, S.A., and Aminabhavi, T.M. (2007) Chitosan Nanoparticles for Prolonged Delivery of Timolol Maleate. Drug Develop. Ind. Pharm., 33(11):1254-1262
77. de Campos, A., et al. (2004) Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity. Pharm. Res., 21(5):803-810
78. Alonso, M.J. and A. Sánchez. (2010). The potential of chitosan in ocular drug delivery. J. Pharm. and Pharmacology, 55(11):1451-1463
79. Fernández-Urrusuno, R., et al. (1999) Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res., 16(10):1576-1581
80. Sun, Y., et al. (2009) Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy. Nanotechnology, 20(13):135102
81. Huang, M., Khor, E., and Lim, L.-Y. (2004) Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharm. Res., 21(2):344-353
82. Huang, M., et al. (2002) Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm. Res., 19(10):1488-1494
83. Xing, K., et al. (2008) Antibacterial activity of oleoyl-chitosan nanoparticles: A novel antibacterial dispersion system. Carbohyd. Polym., 74(1):114-120
84. Vila, A., et al. (2002) Design of biodegradable particles for protein delivery. J. Control. Release, 78(1-3):15-24
85. Gan, Q., andWang, T. (2007) Chitosan nanoparticle as protein delivery carrier-Systematic examination of fabrication conditions for efficient loading and release. Colloid Surf. B, 59(1):24-34
86. Hu, Y., et al. (2002) Synthesis and characterization of chitosanpoly (acrylic acid) nanoparticles. Biomaterials, 23(15):3193-3201
87. Wang, J., et al. (2010) Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropylchitosan nanoparticles. Biomaterials, 31(15):4426-4433
88. Mansouri, S., et al. (2006) Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials, 27(9):2060-2065
89. Borges, O., et al. (2008) Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. Eur. J. Pharm. Biopharm., 69(2): 405-416
90. Csaba, N., Garcia-Fuentes, M., and Alonso, M. (2009) Nanoparticles for nasal vaccination. Adv. Drug Del. Rev., 61(2):140-157
91. Khatri, K., et al. (2008) Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int. J. Pharm., 354(1-2):235-241
92. Wilson, B., et al. (2010) Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomed: Nanotechnol. Biol. Med., 6(1):144-152
93. Wang, X., Chi, N., and Tang, X. (2008) Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur. J. Pharm. Biopharm., 70(3):735-740
94. Grenha, A., Seijo, B., and Remuñán-López, C. (2005) Microencapsulated chitosan nanoparticles for lung protein delivery. Eur. J. Pharm. Sci. 25(4-5):427-437
95. Colonna, C., et al. (2008) Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy. Eur. J. Pharm. Biopharm., 70(1):58-65
96. Banerjee, T., et al. (2002) Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int. J. Pharm., 243(1-2):93-105
97. Alishahi, A., et al. (2011) Shelf life and delivery enhancement of vitamin C using chitosan nanoparticles. Food Chem. 126(3):935-940
98. Wu, Y., et al. (2005) Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int. J. Pharm., 295(1-2):235-245
99. Huang, X., et al. (2009) Preparation and pharmacodynamics of low-molecular-weight chitosan nanoparticles containing insulin. Carbohyd. Polym., 76(3):368-373
100. Wang, Y., et al. (2008) Adsorption of bovin serum albumin (BSA) onto the magnetic chitosan nanoparticles prepared by a microemulsion system. Bioresource Technol., 99(9):3881-3884
101. Rejinold, N., et al. (2010) Biodegradable and thermo-sensitive chitosan-g-poly (N-vinylcaprolactam) nanoparticles as a 5-fluorouracil carrier. Carbohyd. Polym., 83(2):776-786
102. Qi, J., et al. (2010) Nanoparticles with dextran/chitosan shell and BSA/chitosan Coreá-ÁDoxorubicin loading and delivery. Int. J. Pharm., 393(1):177-185
103. Akhlaghi, S.P., et al. (2010) Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines. Nanomed.: Nanotechnol. Biol. Med., 6(5):689-697
104. Parveen, S., et al. (2010) Enhanced antiproliferative activity of carboplatin-loaded chitosan-Alginate nanoparticles in a retinoblastoma cell line. Acta Biomater., 6(8):3120-3131
105. Min, K.H., et al. (2008) Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J. Control. Release, 127(3):208-218
106. Ajun, W., et al. (2009) Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study. Carbohyd. Polym., 75(4):566-574
107. Zhi, J., Wang, Y., and Luo, G. (2005) Adsorption of diuretic furosemide onto chitosan nanoparticles prepared with a water-in-oil nanoemulsion system. Reactive Func. Polym., 65(3):249-257
108. Dev, A., et al. (2010) Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications. Carbohyd. Polym., 80(3):833-838
109. Amorim, C.d.M., et al. (2010) Antioxidant idebenone-loaded nanoparticles based on chitosan and N-carboxymethylchitosan. Nanomed.: Nanotechnol. Biol. Med., 6(6):745-752
110. Oyarzun-Ampuero, F.A., et al. (2009) Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int. J. Pharm., 381(2):122-129
111. Anitha, A., et al. (2011) Preparation; characterization; in vitro drug release and biological studies of curcumin loaded dextran sulfatechitosan nanoparticles. Carbohyd. Polym., 84(3):1158-1164
112. Keawchaoon, L., and Yoksan, R. (2011) Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles. Colloid Surface B, 84(1):163-171
113. Hafner, A., et al. (2009) Melatonin-loaded lecithin/chitosan nanoparticles: Physicochemical characterisation and permeability through Caco-2 cell monolayers. Int. J. Pharm., 381(2):205-213
114. Patil, S.B., and Sawant, K.K. Chitosan microspheres as a delivery system for nasal insufflation. Colloid Surface B, 84(2):384-389
115. Paolicelli, P., et al. (2009) Chitosan nanoparticles for drug delivery to the eye. Expet Opin. Drug Deliv., 6(3):239-253
116. Sinha, V.R., et al. (2004) Chitosan microspheres as a potential carrier for drugs. Int. J. Pharm., 274(1-2):1-33
117. Basu, S.K., Kavitha, K., and Rupeshkumar, M. Evaluation of Ketorolac Tromethamine Microspheres by Chitosan/Gelatin B Complex Coacervation. Sci. Pharma., 2010. 78(1):79
118. Roy, S., et al. (2009) Effect of method of preparation of chitosan microspheres of mefenamic acid. Int. J. Pharm. Sci. Drug Res., 1(1):36-42
119. Liu, X., et al. (2004) Swelling behaviour of alginate-chitosan microcapsules prepared by external gelation or internal gelation technology. Carbohyd. Polym., 56(4):459-464
120. Wittaya-Areekul, S., Kruenate, J., and Prahsarn, C. (2006) Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int. J. Pharm., 312(1-2):113-118
121. Shanmuganathan, S., et al. (2008) Preparation and characterization of chitosan microspheres for doxycycline delivery. Carbohyd. Polym., 73(2):201-211
122. Zhang, Y., et al. (2011) Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Eur. J. Pharm. Biopharm., 77(1):11-19
123. El-Hameed, M., and Kellaway, I. (1997) Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intra-nasal delivery systems. Eur. J. Pharm. Biopharm., 44(1):53-60
124. Longo, W.E., et al. (1982) Preparation of hydrophilic albumin microspheres using polymeric dispersing agents. J. Pharm. Sci., 71(12):1323-1328
125. Jameela, S., and Jayakrishnan, A. (1995) Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: Studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials, 16(10):769-775
126. Gupta, K.C., and Jabrail, F.H. (2007) Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman. Carbohyd. Res., 342(15):2244-2252
127. Amidi, M., et al. (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv. Drug Delivery Rev., 62(1):59-82
128. Giunchedi, P., et al. (2002) Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur. J. Pharm. Biopharm., 53(2):233-239
129. Van der Lubben, I., et al. (2001) Chitosan microparticles for oral vaccination::: Preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials, 22(7):687-694
130. Lorenzo-Lamosa, M.L., et al. (1998) Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control. Release, 52(1-2):109-118
131. van der Lubben, I., et al. (2001) Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci., 14(3):201-207
132. Huang, X., et al. (2009) Preparation and pharmacodynamics of low-molecular-weight chitosan nanoparticles containing insulin. Carbohyd. Polym., 76(3):368-373
133. Amidi, M., et al. (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv. Drug Delivery Rev., 62(1):59-82
134. Kang, M., Cho, C., and Yoo, H. (2009) Application of chitosan microspheres for nasal delivery of vaccines. Biotechnol. Adv., 27(6):857-865
135. Remuñán-López, C., et al. (1998) Development of new chitosancellulose multicore microparticles for controlled drug delivery. Eur. J. Pharm. Biopharm., 45(1):49-56. Chitosan-Based Delivery Systems on a Length Scale 141
136. Simonoska Crcarevska, M., Glavas Dodov, M., and Goracinova, K. (2008) Chitosan coated Ca-Alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Eur. J. Pharm. Biopharm., 68(3):565-578
137. Jose, S., et al. (2011) Colon specific chitosan microspheres for chronotherapy of chronic stable angina. Colloids Surface B, 83(2):277-283
138. Díez-Municio, M., et al. (2011) Supercritical CO2 impregnation of lactulose on chitosan: A comparison between scaffolds and microspheres form. The Journal of Supercritical Fluids. 57(1):73-79
139. Maestrelli, F., et al. (2008) Microspheres for colonic delivery of ketoprofen-hydroxypropyl-[beta]-cyclodextrin complex. Eur. J. Pharm. Sci., 34(1):1-11
140. Zhang, W., et al. (2008) Chitosan and β -cyclodextrin microspheres as pulmonary sustained delivery systems. J. Wuhan U. Technol. Mater. Sci., 23(4):541-546
141. Vasconcellos, F., Goulart, G., and Beppu, M. (2011) Production and characterization of chitosan microparticles containing papain for controlled release applications. Powder Technol., 205(1):65-70
142. Harris, R., et al. Chitosan nanoparticles and microspheres for the encapsulation of natural antioxidants extracted from Ilex paraguariensis. Carbohyd. Polym., 84(2):803-806
143. Guliyeva, Ü., et al. (2006) Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. Eur. J. Pharm. Biopharm., 62(1):17-25
144. Anumansirikul, N., et al. (2008) UV-screening chitosan nanocontainers: Increasing the photostability of encapsulated materials and controlled release. Nanotechnology, 19:205101
145. Gomaa, Y., et al. (2010) Chitosan microparticles incorporating a hydrophilic sunscreen agent. Carbohyd. Polym., 81(2):234-242
146. Günbeyaz, M., et al. (2010) Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). Eur. J. Pharm. Sci., 41(3-4):531-545
147. Ko, J., et al. (2003) Chitosan microparticle preparation for controlled drug release by response surface methodology. J. Microencapsul., 20(6):791-797
148. Bayomi, M.A., et al. (1998) Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. Pharm. Acta Helvetiae, 73(4):187-192
149. Dhawan, S., and Singla, A. (2003) Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation. Biotech. Histochem., 78(5):243-254
150. Zhang, C., et al. (2008) Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5-fluorouracil. Carbohyd. Polym., 72(3):390-397
151. Glavas Dodov, M., et al. (2009) Wheat germ agglutinin-conjugated chitosan-Ca-Alginate microparticles for local colon delivery of 5-FU: Development and in vitro characterization. Int. J. Pharm., 381(2):166-175
152. Dubey, R., and Parikh, R. (2004) Two-stage optimization process for formulation of chitosan microspheres. AAPS PharmSciTech, 5(1):20-28
153. Chandy, T., et al. (2001) Development of poly (Lactic acid)/chitosan co-matrix microspheres: Controlled release of taxol-heparin for preventing restenosis. Drug Del., 8(2):77-86
154. Bazzo, G., Lemos-Senna, E., and Pires, A. (2009) Poly (3-hydroxybutyrate)/chitosan/ketoprofen or piroxicam composite microparticles: Preparation and controlled drug release evaluation. Carbohyd. Polym., 77(4):839-844
155. Mladenovska, K., et al. (2007) Colon-specific delivery of 5-Aminosalicylic acid from chitosan-Ca-Alginate microparticles. Int. J. Pharm., 342(1-2):124-136
156. Amiji, M. (2007) Tetracycline-containing Chitosan Microspheres for Local Treatment of Helicobacter pylori Infection. Cellulose, 14(1):3-14
157. Ventura, C., et al. (2008) Chitosan microspheres for intrapulmonary administration of moxifloxacin: Interaction with biomembrane models and in vitro permeation studies. Eur. J. Pharm. Biopharm., 68(2):235-244
158. Jameela, S., et al. (1998) Progesterone-loaded chitosan microspheres: A long acting biodegradable controlled delivery system. J. Control. Release, 52(1-2):17-24
159. Babensee, J., McIntire, L., and Mikos, A. (2000) Growth factor delivery for tissue engineering. Pharm. Res., 17(5):497-504
160. Babu, V., Hosamani, K., and Aminabhavi, T. (2008) Preparation and in-vitro release of chlorothiazide novel pH-sensitive chitosan-N, N-dimethylacrylamide semi-interpenetrating network microspheres. Carbohyd. Polym., 71(2):208-217
161. Akbuga, J., and Durmaz, G. (1994) Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Int. J. Pharm., 111(3):217-222
162. Angadi, S., Manjeshwar, L., and Aminabhavi, T. (2010) Interpenetrating Polymer Network Blend Microspheres of Chitosan and Hydroxyethyl Cellulose for Controlled Release of Isoniazid. Int. J. Biol. Macromol., 47(2):171-179
163. Manca, M., et al. (2008) Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles. Colloid Surfaces B, 67(2):166-170
164. Guerrero, S., et al. (2010) Characterization and in vivo evaluation of ketotifen-loaded chitosan microspheres. Carbohyd. Polym., 79(4):1006-1013.
165. Roy, S., et al. (2009) Polymers in Mucoadhesive Drug-Delivery Systems: A Brief Note. Design. Monom. Polym., 12:483-495
166. Mishra, R., et al. (2008) Preparation and characterization of amidated pectin based hydrogels for drug delivery system. J. Mater. Sci., 19(6):2275-2280
167. Sutar, P., et al. (2008) Development of pH sensitive polyacrylamide grafted pectin hydrogel for controlled drug delivery system. J. Mater. Sci., 19(6):2247-2253
168. Pal, K., Banthia, A.K., and Majumdar, D.K. Effect of heat treatment of starch on the properties of the starch hydrogels. Mater. Lett., 62(2):215-218
169. Pal, K., Banthia, A.K., and Majumdar, D.K. (2007) Preparation and Characterization of Polyvinyl Alcohol-Gelatin Hydrogel Membranes for Biomedical Applications. AAPS PharmSciTech., 8(1): E1-E5
170. Pal, K., Banthia, A.K., and Majumdar, D.K. (2006) Polyvinyl alcoholgelatin patches of salicylic acid: Preparation, characterization and drug release studies. J. Biomater. Appl., 21(1):75-91
171. Pal, K., Banthia, A., and Majumdar, D. (2007) Biomedical evaluation of polyvinyl alcohol-gelatin esterified hydrogel for wound dressing. J. Mater. Sci., 18(9):1889-1894
172. Pal, K., Banthia, A.K., and Majumdar, D.K. (2006) Preparation of Novel pH-Sensitive Hydrogels of Carboxymethyl Cellulose Acrylates: A Comparative Study. Mater. Manuf. Processes, 21(8): 877-882
173. Pal, K., Banthia, A.K., and Majumdar, D.K. (2006) Development of carboxymethyl cellulose acrylate for various biomedical applications. Biomed. Mater., 1(2):85-91
174. Pal, K., Banthia, A.K., and Majumdar, D.K. (2006) Characterization of prepared corn starch-based hydrogel membranes. J. Appl. Biomater. Biomech., 4(1):38-44
175. Pal, K., Banthia, A.K., and Majumdar, D.K. (2006) Preparation of transparent starch based hydrogel membrane with potential application as wound dressing. Trends Biomater. Artif. Organs, 20(1):59-67
176. Bhattarai, N., Gunn, J., and Zhang, M. (2010) Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Del. Rev., 62(1):83-99
177. Amin, S., Rajabnezhad, S., and Kohli, K. (2009) Hydrogels as potential drug delivery systems. Sci. Res. Essays, 4(11):1175-1183
178. Ta, H.T., et al. (2009) Chitosan-dibasic orthophosphate hydrogel: A potential drug delivery system. Int. J. Pharm., 371(1-2):134-141
179. Jeong, B., Kim, S.W., and Bae, Y.H. (2002) Thermosensitive sol-gel reversible hydrogels. Adv. Drug Del. Rev., 54(1):37-51
180. Bhattarai, N., et al. (2005) PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J. Control. Release, 103(3):609-624
181. Berger, J., et al. (2004) Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm., 57(1):19-34
182. Tanabe, T., Okitsu, N., and Yamauchi, K. (2004) Fabrication and characterization of chemically crosslinked keratin films. Mater. Sci. Eng.: C, 24(3):441-446
183. Huang, R.-H., et al. (2007) Hexamethylene diisocyanate crosslinking 2-hydroxypropyltrimethyl ammonium chloride chitosan/poly(acrylonitrile) composite nanofiltration membrane. J. Appl. Polym. Sci., 105(2):673-679
184. Ono, K., et al. (2000) Photocrosslinkable chitosan as a biological adhesive. J. Biomed. Mater. Res., 49(2):289-295
185. Hussain, A.A. (1998) Intranasal drug delivery. Adv. Drug Del. Rev., 29(1-2):39-49
186. Ugwoke, M.I., et al. (2005) Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv. Drug Del. Rev., 57(11):1640-1665
187. Kublik, H., and Vidgren, M.T. (1998) Nasal delivery systems and their effect on deposition and absorption. Adv. Drug Del. Rev., 29(1-2):157-177
188. Dodane, V., Amin Khan, M., and Merwin, J.R. (1999) Effect of chitosan on epithelial permeability and structure. Int. J. Pharm., 182(1):21-32
189. Nakamura, K., et al. (1999) Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery. J. Control. Release, 61(3):329-335
190. Wu, J., et al. (2007) A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system. Biomaterials, 28(13):2220-2232
191. Agrawal, A.K., et al. (2010) Development and characterization of in situ gel system for nasal insulin delivery. Pharmazie, 65(3):188-193
192. Fang, J.-Y., et al. (2008) Temperature-sensitive hydrogels composed of chitosan and hyaluronic acid as injectable carriers for drug delivery. Eur. J. Pharma. Biopharm., 68(3):626-636
193. Risbud, M.V., et al. (2000) pH-sensitive freeze-dried chitosanpolyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J. Control. Release, 68(1):23-30
194. 48
195. Ta, H.T., et al. (2009) A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy. Biomaterials, 30(27):4815-4823
196. Ek, E.T.H., Dass, C.R., and Choong, P.F.M. (2006) Pigment epithelium-derived factor: A multimodal tumor inhibitor. Molecul. Cancer Therap., 5(7):1641-1646
197. Ta, H.T., et al. (2009) A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma. Biomaterials, 30(21):3605-3613
198. Han, H.D., et al. (2008) A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. Int. J. Pharm., 350(1-2):27-34
199. Seo, S.H., et al. (2009) Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity. Clin. Exp. Metastasis, 26(3):179-187
200. Ramakrishnan, R., et al. (2010) Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice. J. Clin. Invest., 120(4):1111-1124
201. Fouda, M.M.G., et al. (2009) Use of chitosan/polyamine biopolymers based cotton as a model system to prepare antimicrobial wound dressing. Int. J. Diab. Mellitus, 1(1):61-64
202. Jayakumar, R., et al. () Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol. Adv. 29(3):322-337
203. Ueno, H., Mori, T., and Fujinaga, T. (2001) Topical formulations and wound healing applications of chitosan. Adv. Drug Del. Rev., 52(2):105-115
204. Yang, X., et al. (2008) Investigation of PVA/ws-chitosan hydrogels prepared by combined [gamma]-irradiation and freeze-thawing. Carbohyd. Polym., 73(3):401-408
205. Zhao, L., et al. (2003) Synthesis of antibacterial PVA/CM-chitosan blend hydrogels with electron beam irradiation. Carbohyd. Polym., 53(4):439-446
206. Martin, L., et al. (2003) Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur. J. Pharm. Biopharm., 55(1):35-45
207. Senel, S., et al. (2000) Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int. J. Pharm., 193(2):197-203
208. Feng, J., Zhao, L., and Yu, Q. (2004) Receptor-mediated stimulatory effect of oligochitosan in macrophages. Biochem. Biophys. Res. Comm., 317(2):414-420
209. Shantha, K.L., and Harding, D.R.K. (2000) Preparation and in-vitro evaluation of poly[N-vinyl-2-pyrrolidone-polyethylene glycol diacrylate]-chitosan interpolymeric pH-responsive hydrogels for oral drug delivery. Int. J. Pharm., 207(1-2):65-70
210. Mitra, S., et al. (2001) Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control. Release, 74(1-3):317-323
211. Ishihara, M., et al. (2006) Chitosan hydrogel as a drug delivery carrier to control angiogenesis. J. Artif. Organs, 9(1):8-16
212. Ruel-Gariépy, E., et al. (2004) A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur. J. Pharm. Biopharm., 57(1):53-63
213. Patel, V.R., and Amiji, M.M. (1996) Preparation and characterization of freeze-dried chitosan-poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach. Pharm. Res., 13(4):588-593
214. Makarand, V., and Risbud, R.R.B. (2000) Polyacrylamide-chitosan hydrogels: In vitro biocompatibility and sustained antibiotic release studies. Drug Del., 7(2):69-75
215. Yao, K.D., et al. (1995) Investigation of pH-sensitive drug delivery system of chitosan/gelatin hybrid polymer network. Polym. Int., 38(1):77-82
216. Berger, J., et al. (2004) Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur. J. Pharm. Biopharm., 57(1):35-52
217. Dash, M., et al. (2011) Chitosan-A versatile semi-synthetic polymer in biomedical applications. Prog. Polym. Sci., 36(8):981-1014
218. Jiskoot, W., et al. (2009) Immunological Risk of Injectable Drug Delivery Systems. Pharm. Res., 26(6):1303-1314
219. Liu, Y., et al. (2011) Preparation and characterization of [alpha]-galactosidase-loaded chitosan nanoparticles for use in foods. Carbohyd. Polym., 83(3):1162-1168
220. Wang, Q., et al. (2010) Norcantharidin-Associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery. Nanomed.: Nanotechnol. Biol. Med., 6(2):371-381
221. Mao, S., Sun, W., and Kissel, T. (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv. Drug Del. Rev., 62(1):12-27
222. Patil, S.B., and Sawant, K.K. (2011) Chitosan microspheres as a delivery system for nasal insufflation. Colloid Surfaces B, 84(2):384-389
223. Ying, X.-Y., et al. (2011) Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin. Carbohyd. Polym., 84(4):1357-1364
224. Jingou, J., et al. (2011) Preparation, characterization of hydrophilic and hydrophobic drug in combine loaded chitosan/cyclodextrin nanoparticles and in vitro release study. Colloid Surfaces B, 83(1):103-107